project id: TCGA-UCEC; case submitter id: TCGA-AJ-A3BF; source center: 23; state: released; a260 a280 ratio: 1.37; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.3; age at index: 65; days to birth: -23906; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 23906; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 551.0; figo stage: Stage IIIC2; icd 10 code: C54.1; last known disease status: not reported; morphology: 8460/3; primary diagnosis: Papillary serous cystadenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 92; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-AJ-A3BF-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 3.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;